How Unlicensed Triple Reciprocal Activation (GLP-1/GIP/GCGR) Outperforms Early-Stage Mono-Therapies in Trials
The metabolic medicine landscape has been completely transformed by the discovery of incretin-based therapies. First-generation interventions successfully demonstrated that mimicking natural gut hormones could significa…
